Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05129228 · ClinicalTrials.gov registry record · NA
Optical Coherence Tomography of the Saphenous Vein Graft
A NA study of Coronary Bypass Graft Stenosis, sponsored by St. Francis Hospital, New York.
- Recruiting
- Registry status
- NA
- Development phase
- 760
- Enrollment target
- 1
- Study location
NCT05129228 is a NA study of Coronary Bypass Graft Stenosis that is actively recruiting participants, run by St. Francis Hospital, New York. The registered enrollment target is 760 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05129228, a NA study of Coronary Bypass Graft Stenosis, is actively recruiting participants, sponsored by St. Francis Hospital, New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 760 participants
- Enrollment target
- 1
- Study location
Study Summary
OCTOCAB is a prospective, randomized (1:1), single-center trial. The purpose of this study is to determine whether intravascular optical coherence tomography (OCT) guided saphenous vein grafting in coronary artery bypass surgery will reduce the rate of early vein graft failure (VGF).
Conditions Studied
Interventions
- DEVICE OCT-guided saphenous vein CABG
Study Locations (1)
New York
- St Francis Hospital - Roslyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 760 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2026-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05129228
The ClinicalTrials.gov registry entry for NCT05129228 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 760 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Francis Hospital, New York, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Bypass Graft Stenosis appearing as the primary indexed condition, and to 1 intervention - of which OCT-guided saphenous vein CABG is the first listed.
NCT05129228 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05129228 about?
NCT05129228 is a clinical study titled "Optical Coherence Tomography of the Saphenous Vein Graft". OCTOCAB is a prospective, randomized (1:1), single-center trial. The purpose of this study is to determine whether intravascular optical coherence tomography (OCT) guided saphenous vein grafting in coronary artery bypass surgery will reduce the rate of early vein graft failure (VGF).
What is the current status of trial NCT05129228?
This trial is currently recruiting. It is a NA study. The enrollment target is 760 participants. The study started on 2022-04-04. Estimated completion is 2026-04-04.
What conditions does trial NCT05129228 study?
This clinical trial studies the following conditions: Coronary Bypass Graft Stenosis.
What interventions are being tested in trial NCT05129228?
The interventions under investigation include: OCT-guided saphenous vein CABG (DEVICE).
Who is sponsoring clinical trial NCT05129228?
This trial is sponsored by St. Francis Hospital, New York, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05129228 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Bypass Graft Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.